Monoclonal antibodies directed to the erbB-2 receptor inhibit in vivo tumour cell growth.

Four monoclonal antibodies (MAbs) specific for the extracellular domain of the human erbB-2/HER2 protein (FRP5, FSP16, FWP51 and FSP77) have been isolated (Harwerth et al., J. Biol. Chem., 267, 15160-15167, 1992). In this paper we describe the effects of erbB-2 specific MAb administration on the tum...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Harwerth, I. M., Wels, W., Schlegel, J., Müller, M., Hynes, N. E.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group 1993
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC1968669/
https://ncbi.nlm.nih.gov/pubmed/7903153
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia